menu search

2 top biotech stocks ready for a bull run

With more to their businesses than COVID-19 revenue, these two companies have huge market opportunities ahead....

March 9, 2022, 7:34 am

7 biotech stocks with key catalysts in march

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. The post 7 ...

March 9, 2022, 6:24 am

Nuvalent to present new preclinical data on ros1-selective inhibitor nvl-520 and alk-selective inhibitor nvl-655 at aacr annual meeting 2022

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Nuvalent, Inc., (Nasdaq: NUVL) a biotechnology company creating precisely targeted therapies for clin...

March 8, 2022, 5:38 pm

Omega therapeutics to present preclinical data for otx-2002 at the american association for cancer research annual meeting 2022

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a development-stage biotechnology company pioneeri...

March 8, 2022, 5:05 pm

Adaptive biotechnologies lays off about 100 people, 12% of headcount, to ‘streamline our workforce'

Adaptive Biotechnologies is laying off 12% of its workforce, or about 100 employees, GeekWire has learned....

March 8, 2022, 4:47 pm

Sqz biotechnologies to present new enhanced apc platform preclinical findings and envoy-001 phase 1/2 clinical trial in progress poster at the american association for cancer research 2022 annual meet

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple the...

March 8, 2022, 4:45 pm

Sqz biotechnologies to present new enhanced apc platform preclinical findings and envoy-001 phase 1/2 clinical trial in progress poster at the american association for cancer research 2022 annual meet

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple the...

March 8, 2022, 4:45 pm

Why crispr therapeutics stock is soaring today

Despite big gains today, the biotech specialist's share price is still down roughly 46% over the past y...

March 8, 2022, 4:18 pm

Learning lessons from 3 stocks flourishing in a desperate biotech bear market

biotech has been the worst performing sector of the stock market across the past 12 months....

March 8, 2022, 2:25 pm

Sigilon therapeutics to present at the barclays global healthcare conference

CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop function...

March 8, 2022, 7:00 am

Is a rise imminent for intellia therapeutics stock after 30% fall in a month?

The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31%...

March 8, 2022, 6:30 am

Why bluebird bio stock is sinking today

The biotech's financial position has some investors worried....

March 7, 2022, 2:58 pm

Why bluebird bio stock is sinking today

The biotech's financial position has some investors worried....

March 7, 2022, 2:58 pm

Why bluebird bio stock is sinking today

The biotech's financial position has some investors worried....

March 7, 2022, 2:58 pm

Why allakos stock sank 17.3% in february

The biotech stock has lost roughly 96% of its value over the last year....

March 7, 2022, 10:39 am

Why allakos stock sank 17.3% in february

The biotech stock has lost roughly 96% of its value over the last year....

March 7, 2022, 10:39 am

Why allakos stock sank 17.3% in february

The biotech stock has lost roughly 96% of its value over the last year....

March 7, 2022, 10:39 am

Neubase to present at oppenheimer's 32nd annual healthcare conference

PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech...

March 7, 2022, 8:00 am

Neubase to present at oppenheimer's 32nd annual healthcare conference

PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech...

March 7, 2022, 8:00 am

Neubase to present at oppenheimer's 32nd annual healthcare conference

PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech...

March 7, 2022, 8:00 am


Search within

Pages Search Results: